Rector Advisor, Vice Dean, and Faculty Member - Istanbul Kent University, Faculty of Pharmacy, Departmant of Pharmocology
Visiting Researcher&Lecturer - University College London, Mechanical Engineering and Faculty of Medicine, UK
Visiting Lecturer - University of Aveiro, Faculty of Biomedical Engineering, Portugal
Visiting Researcher&Lecturer - University College London, Mechanical Engineering and Faculty of Medicine, UK
Visiting Lecturer - University of Aveiro, Faculty of Biomedical Engineering, Portugal
Editorial note
Map of Health content is prepared with an evidence-based approach. References are provided for transparency.
Medical disclaimer
This content is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. If you have an urgent medical concern, seek immediate care.
"HPV vaccines, supported by scientific data worldwide, are a safe and effective protective measure for both yourself and your loved ones."
On this page:
THINGS YOU NEED TO KNOW ABOUT HPV VACCINES
| Feature | Information |
|---|---|
| Vaccine Type | Bivalent Virus–Like Particle |
| Vaccination Schedule | Administered in 2–3 doses (2nd dose after 1–2 months, 3rd dose after 6 months) |
| Benefits of the Vaccine | Reduces the risk of cervical cancer |
| HPV Types Covered | HPV 16, 18 |
| Vaccinated Individuals | Mainly for females; also approved for males in some regions |
| Starting Age for Vaccination | 9 years and older |
| Feature | Information |
|---|---|
| Vaccine Type | Quadrivalent Virus–Like Particle |
| Vaccination Schedule | Administered in 2–3 doses (2nd dose after 2 months, 3rd dose after 6 months) |
| Benefits of the Vaccine | Prevents genital warts, cervical cancer, and other HPV-related cancers |
| HPV Types Covered | HPV 6, 11, 16, 18 |
| Vaccinated Individuals | Both males and females |
| Starting Age for Vaccination | 9 years and older |
| Feature | Information |
|---|---|
| Vaccine Type | 9-valent Virus–Like Particle |
| Vaccination Schedule | Administered in 2–3 doses (2nd dose after 2 months, 3rd dose after 6 months) |
| Benefits of the Vaccine | Provides protection against a broader range of HPV types, helps prevent cancers and warts |
| HPV Types Covered | HPV 6, 11, 16, 18, 31, 33, 45, 52, 58 |
| Vaccinated Individuals | Both males and females |
| Starting Age for Vaccination | 9 years and older |
Assoc. Prof. Muhammet Emin Çam
Rector Advisor, Vice Dean, and Faculty Member - Istanbul Kent University, Faculty of Pharmacy, Departmant of Pharmocology
Visiting Researcher&Lecturer - University College London, Mechanical Engineering and Faculty of Medicine, UK
Visiting Lecturer - University of Aveiro, Faculty of Biomedical Engineering, Portugal
Visiting Researcher&Lecturer - University College London, Mechanical Engineering and Faculty of Medicine, UK
Visiting Lecturer - University of Aveiro, Faculty of Biomedical Engineering, Portugal
